Transposagen Overview

  • Founded
  • 2003

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees
  • Latest Deal Type
  • M&A

Transposagen General Information

Description

Developer of biotechnology drugs intended to improve drug discovery and development research. The company is biotechnology-based and provides genetically modified rat models to create improved preclinical models, performing cell engineering and in vitro and in vivo oncology studies for clients, enabling researchers to discover drugs and treat diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 535 West Second Street
  • Suite L102
  • Lexington, KY 40508
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transposagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jan-2018 00.000 Completed Generating Revenue
4. Grant 21-Jun-2013 00.00 00.000 Completed Generating Revenue
3. Angel (individual) 18-Jul-2012 00000 00.000 Completed Generating Revenue
2. Angel (individual) 20-Dec-2011 $725K $725K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Transposagen’s complete valuation and funding history, request access »

Transposagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotechnology drugs intended to improve drug discovery and development research. The company is biotechnolo
Biotechnology
Lexington, KY
20 As of 2015
00.000
000000&0 00.000

000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
0000000000000
Mont-Saint-Guibert, Belgium
000 As of 0000
00000
000000000 00000

00000

isi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit i
00000 00000000000000
Littleton, CO
00 As of 0000
00.00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Transposagen Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celyad Oncology Formerly VC-backed Mont-Saint-Guibert, Belgium 000 00000 000000000 00000
00000 00000000000 Formerly PE-Backed Littleton, CO 00 000000&0
000 00000000 Corporation Dublin, Ireland
0000000 0000000000 Formerly VC-backed Berkeley, CA 000 00000 00000000 00000
0000000 00000000 Venture Capital-Backed Milpitas, CA 00 000.00 0000000000 000.00
You’re viewing 5 of 35 competitors. Get the full list »

Transposagen Patents

Transposagen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2891510-C Site-specific enzymes and methods of use Active 16-Nov-2012 0000000000
ES-2778033-T3 Site-specific enzymes and methods of use Active 16-Nov-2012 0000000000
US-10844361-B2 Site-specific enzymes and methods of use Active 16-Nov-2012 0000000000
US-20200199553-A1 Site-specific enzymes and methods of use Active 16-Nov-2012 0000000000
US-20210062170-A1 Site-specific enzymes and methods of use Pending 16-Nov-2012 C07K14/195
To view Transposagen’s complete patent history, request access »

Transposagen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transposagen Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view Transposagen’s complete investors history, request access »